Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,105 | 139 | 98.7% |
| Education | $28.79 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $533.09 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $370.18 | 25 | $0 (2024) |
| Novo Nordisk Inc | $278.33 | 19 | $0 (2023) |
| Amgen Inc. | $178.00 | 12 | $0 (2022) |
| Lilly USA, LLC | $150.90 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $124.07 | 10 | $0 (2021) |
| Boston Scientific Corporation | $118.10 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $72.03 | 5 | $0 (2019) |
| PFIZER INC. | $63.56 | 5 | $0 (2021) |
| Abbott Laboratories | $43.57 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113.96 | 7 | AstraZeneca Pharmaceuticals LP ($71.79) |
| 2023 | $85.95 | 6 | AstraZeneca Pharmaceuticals LP ($28.47) |
| 2022 | $298.79 | 14 | Boston Scientific Corporation ($118.10) |
| 2021 | $239.72 | 16 | AstraZeneca Pharmaceuticals LP ($114.01) |
| 2020 | $231.40 | 16 | GlaxoSmithKline, LLC. ($64.59) |
| 2019 | $306.13 | 20 | GlaxoSmithKline, LLC. ($70.00) |
| 2018 | $447.53 | 34 | GlaxoSmithKline, LLC. ($156.77) |
| 2017 | $410.68 | 28 | GlaxoSmithKline, LLC. ($149.34) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Endocrinology | ||||||
| 05/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Respiratory | ||||||
| 03/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: VACCINES | ||||||
| 08/29/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 06/01/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 03/31/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/17/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 02/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/07/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: KRYSTEXXA | ||||||
| 11/30/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes Care | ||||||
| 09/28/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Neuroscience | ||||||
| 08/11/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Inflammation | ||||||
| 08/10/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes Care | ||||||
| 06/30/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Neuroscience | ||||||
| 04/29/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 03/29/2022 | Boston Scientific Corporation | General - Angioplasty (Device) | Food and Beverage | In-kind items and services | $118.10 | General |
| Category: General - Angioplasty_PI | ||||||
| 03/26/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Diabetes | ||||||
| 02/04/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,211 | 2,068 | $248,690 | $132,711 |
| 2022 | 17 | 1,303 | 2,010 | $214,495 | $123,147 |
| 2021 | 18 | 1,265 | 2,458 | $241,265 | $145,537 |
| 2020 | 19 | 1,342 | 2,801 | $288,443 | $155,702 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 238 | 503 | $65,893 | $27,278 | 41.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 178 | 178 | $30,260 | $21,816 | 72.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 88 | 254 | $24,140 | $15,663 | 64.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 78 | 95 | $24,065 | $12,772 | 53.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 204 | 346 | $28,372 | $11,014 | 38.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 54 | $18,530 | $9,035 | 48.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 72 | $9,720 | $6,702 | 68.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 75 | $13,860 | $6,409 | 46.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 76 | 94 | $8,930 | $5,831 | 65.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 60 | 131 | $6,550 | $5,094 | 77.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 63 | 63 | $6,930 | $4,776 | 68.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 69 | 69 | $1,875 | $1,717 | 91.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $2,200 | $1,690 | 76.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $3,920 | $1,502 | 38.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 85 | $2,125 | $737.19 | 34.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 18 | 22 | $1,320 | $674.18 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 273 | 562 | $57,926 | $30,979 | 53.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 179 | 190 | $34,900 | $18,847 | 54.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 215 | $30,275 | $17,252 | 57.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 194 | $18,654 | $10,697 | 57.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 59 | $15,045 | $9,100 | 60.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 108 | 112 | $9,480 | $7,665 | 80.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 46 | 46 | $7,820 | $5,693 | 72.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 110 | 135 | $9,045 | $4,907 | 54.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 59 | 140 | $7,000 | $4,244 | 60.6% |
About Dr. Harold Harvey, M.D
Dr. Harold Harvey, M.D is a Internal Medicine healthcare provider based in Beckley, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174630321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harold Harvey, M.D has received a total of $2,134 in payments from pharmaceutical and medical device companies, with $113.96 received in 2024. These payments were reported across 141 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,105).
As a Medicare-enrolled provider, Harvey has provided services to 5,121 Medicare beneficiaries, totaling 9,337 services with total Medicare billing of $557,096. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Allergy & Immunology
- Location Beckley, WV
- Active Since 08/24/2006
- Last Updated 05/13/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174630321
Products in Payments
- FARXIGA (Drug) $259.23
- BREO (Drug) $208.86
- TRELEGY ELLIPTA (Drug) $179.85
- General - Angioplasty (Device) $118.10
- Ozempic (Drug) $112.22
- XARELTO (Drug) $112.20
- TRULICITY (Drug) $99.58
- SHINGRIX (Biological) $74.53
- Aimovig (Biological) $61.30
- Victoza (Drug) $52.80
- Prolia (Biological) $49.65
- SPIRIVA RESPIMAT (Drug) $43.95
- ANORO (Drug) $40.59
- Repatha (Biological) $39.67
- ELIQUIS (Drug) $37.04
- SYMBICORT (Drug) $33.26
- FREESTYLE LIBRE 2 (Device) $32.48
- Otezla (Drug) $27.38
- EMGALITY (Drug) $26.39
- BREZTRI AEROSPHERE (Drug) $25.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Beckley
Dr. Saad Zafar, D.o, D.O
Internal Medicine — Payments: $8,608
Dr. Wadih Kabbara, Md, MD
Internal Medicine — Payments: $6,045
Dr. Mustafa Rahim, M.d, M.D
Internal Medicine — Payments: $5,507
Dr. Hassan Jafary, Md, MD
Internal Medicine — Payments: $3,463
Dr. Joseph Morrello, D.o, D.O
Internal Medicine — Payments: $3,183
Dr. Surayia Hasan, Md, MD
Internal Medicine — Payments: $3,036